F. Horaud

发表

A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice

F. Tekaia, A. Martin, M. Tardy-Panit, 1993, Journal of virology.

Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature

C. Christodoulou, P. Minor, A. Macadam, 1990, Journal of virology.

Polio vaccine: From empiricism and efficacyto scientific knowledge

R. Crainic, B. Blondel, F. Horaud, 1985 .

Molecular pathogenesis of type 2 poliovirus in mice

R. Crainic, F. Horaud, T. Couderc, 1989, European Journal of Epidemiology.

Antigenic variation of poliovirus studied by means of monoclonal antibodies.

R. Crainic, B. Blondel, F. Horaud, 1984, Reviews of infectious diseases.

temperature.revertants selected at high neurovirulence in monkeys infected with Sabin Mapping of mutations associated with

A. Macadam, F. Horaud, L. F. Taffs, 2013 .

type 1 contributes to attenuation in mice. A mutation in the RNA polymerase of poliovirus

F. Tekaia, A. Martin, M. Tardy-Panit, 2012 .

A Mutation intheRNA Polymerase ofPoliovirus Type1 Contributes toAttenuation inMice

F. Tekaia, M. Tardy-Panit, B. Blondel, 1993 .

Molecular pathogenesis of neural lesions induced by poliovirus type 1.

C. Christodoulou, R. Crainic, F. Horaud, 1989, The Journal of general virology.

Comparative expression of the hepatitis B surface antigen gene in biochemically transformed human, simian and murine cells.

P. Kourilsky, F. Horaud, F. Colbère-Garapin, 1985, The Journal of general virology.

Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell

B. Blondel, F. Horaud, T. Couderc, 1993, Journal of virology.

Pharmaceuticals and viral safety: a global view

N. Dumey, F. Horaud, D. Larzul, 2000 .

Albert B. Sabin.

F. Horaud, J. Melnick, 1993, Biologicals : journal of the International Association of Biological Standardization.

Viral Vaccines and Cell Substrate: A "Historical" Debate

F. Horaud, 2011 .

Poliovirus permissivity and specific receptor expression on human endothelial cells.

R. Crainic, F. Horaud, T. Couderc, 1990, Virology.

Viral vaccines and residual cellular DNA.

F. Horaud, 1995, Biologicals : journal of the International Association of Biological Standardization.

DNA, dragons and sanity.

F. Horaud, J. Petricciani, 1995, Biologicals : journal of the International Association of Biological Standardization.

Viral safety of blood derivatives: an overview.

F. Horaud, 1996, Clinical therapeutics.

Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population.

G. Schild, D. Evans, P. Minor, 1986, The Journal of general virology.

Quality of biotechnological products : Derivation and characterisation of cell substrates used for production of biotechnological/biological products : International Conference on Harmonisation (ICH)

F. Brown, F. Horaud, E. Griffiths, 1998 .

Polio vaccine and retroviruses.

F. Horaud, J. Beale, 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

An insight into poliovirus biology.

C. Wychowski, R. Crainic, F. Horaud, 1989, Advances in experimental medicine and biology.

Medicinal and other products and human and animal transmissible spongiform encephalopathies: memorandum from a WHO meeting.

A. Aguzzi, H. Budka, J. Wilesmith, 1997, Bulletin of the World Health Organization.

Identification and characterization of a continuous neutralization epitope (C3) present on type 1 poliovirus.

R. Crainic, B. Blondel, F. Horaud, 1987, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site

R. Crainic, B. Blondel, F. Horaud, 1986, Journal of virology.

Serologic survey of antibodies to cytomegalovirus in women and infants in Lima, Peru.

S. Plotkin, F. Horaud, N. Cabau, 1983, The Journal of infectious diseases.

Adenovirus vectored vaccines.

F. Horaud, 1994 .

Absence of viral sequences in the WHO-Vero Cell Bank. A collaborative study.

F. Horaud, 1992, Developments in biological standardization.

Quality of biotechnological products : Stability testing of biotechnological/ biological products : International Conference on Harmonisation (ICH)

F. Brown, F. Horaud, E. Griffiths, 1998 .

WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (Requirements for biological substances N°50) : Safety of Biological Products Prepared from Mammalian Cell Culture

F. Brown, F. Horaud, E. Griffiths, 1998 .

Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted.

C. Wychowski, R. Crainic, F. Horaud, 1991, The Journal of general virology.

Karyology and tumorigenicity testing requirements: past, present and future.

F. Horaud, J. Petricciani, 1998, Developments in biological standardization.

Ethical and safety considerations for the use in clinical trials of new attenuated poliovirus strains.

F. Horaud, 1993, Developments in biological standardization.